Aug 16, 2022

Merck bags chance to test ADCs based on Starpharma delivery tech

Merck bags chance to test ADCs based on Starpharma delivery tech

"Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based on a dendrimer drug delivery platform", as featured in Fierce Pharma. Read the article here.

 This contains certain forward-looking statements.